Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
The American Journal of Pathology|February 11, 2014
Vascular endothelial growth factor c promotes ovarian carcinoma progression through paracrine and autocrine mechanismsAlessandra Decio, Giulia Taraboletti, Veronica Patton, et al.
Analytica Chimica Acta|November 16, 2018
Past-in-the-Future. Peak detection improves targeted mass spectrometry imagingFrancesca Falcetta, Lavinia Morosi, Paolo Ubezio, et al.
Cancer Research Communications|March 30, 2023
The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with CarboplatinGiulia Dellavedova, Alessandra Decio, Laura Formenti, et al.
Cancers|August 28, 2020
Impact of ERCC1, XPF and DNA Polymerase β Expression on Platinum Response in Patient-Derived Ovarian Cancer XenograftsFederica Guffanti, Maria Francesca Alvisi, Elisa Caiola, et al.
Oncogene|February 3, 2021
The ER stress response mediator ERO1 triggers cancer metastasis by favoring the angiogenic switch in hypoxic conditionsErsilia Varone, Alessandra Decio, Alexander Chernorudskiy, et al.
Intensive Care Medicine Experimental|July 29, 2015
Angiotensin-(1-7) improves oxygenation, while reducing cellular infiltrate and fibrosis in experimental Acute Respiratory Distress SyndromeVanessa Zambelli, Giacomo Bellani, Roberto Borsa, et al.
International Journal of Cancer|May 13, 2018
Tumor progression and metastatic dissemination in ovarian cancer after dose-dense or conventional paclitaxel and cisplatin plus bevacizumabFrancesca Bizzaro, Francesca Falcetta, Elisa D'Agostini, et al.
Scientific Reports|December 22, 2016
Heterogeneity of paclitaxel distribution in different tumor models assessed by MALDI mass spectrometry imagingSilvia Giordano, Massimo Zucchetti, Alessandra Decio, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 14, 2021
L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signalingMarco Giordano, Alessandra Decio, Chiara Battistini, et al.
Molecular Cancer Therapeutics|October 24, 2015
Bevacizumab-Induced Inhibition of Angiogenesis Promotes a More Homogeneous Intratumoral Distribution of Paclitaxel, Improving the Antitumor ResponseMarta Cesca, Lavinia Morosi, Alexander Berndt, et al.
Pageof 3